Catalyst Pharmaceuticals Acquired by Angelini Pharma | Healthcare M&A Deal

Angelini Pharma has acquired Catalyst Pharmaceuticals, a pharmacy business in Delaware, for $31.50. Catalyst Pharmaceuticals is a healthcare company focused on pharmacy-related products and services, supporting Angelini Pharma acquisitions in the U.S. market. The Catalyst Pharmaceuticals acquisition is part of healthcare M&A and merger acquisition activity tied to strategic acquisition plans by Angelini Pharma. The healthcare deals DE structure is a merger acquisition announced for a special stockholder vote, with the Merger Agreement dated May 6, 2026 and a virtual meeting scheduled for July 8, 2026.